BCL2, a marker of anti-apoptotic signaling, is frequently positive in BCOR-CCNB3 sarcomas but is also seen in a wide range of other small round cell tumors, including synovial sarcoma and desmoplastic small round cell tumor (DSRCT). This evidence concerns the gene CCNB3 and sarcoma.